Skip to main content
Log in

Beware of Over-Interpreting Negative Trials

  • Editorial Notes
  • Published:
Journal of Autism and Developmental Disorders Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  • Ratey, J. J., & Gutheil, C. M. (1991). The measurement of aggressive behavior: reflections on the use of the Overt Aggression Scale and the modified Overt Aggression Scale. The Journal of neuropsychiatry and clinical neurosciences, 3, S57–S60.

    PubMed  Google Scholar 

  • Research Units on Pediatric Psychopharmacology (RUPP) Autism Network. (2002). Risperidone in children with autism for serious behavioral problems. New England Journal of Medicine, 347(5), 314–321.

    Article  Google Scholar 

  • Rush, J., & Frances, A. (Eds.) (2000). Expert consensus guideline series. Treatment of psychiatric and behavioral problems in mental retardation. American Journal on Mental Retardation, 105, 159–228.

    Google Scholar 

  • Tunis, S. R., Stryer, D. B., & Clancy, C. M. (2003). Practical clinical trials: Increasing the value of clinical research for decision making in clinical and health policy. JAMA, 290(12), 1624–1632.

    Article  PubMed  Google Scholar 

  • Tyrer P., Oliver-Africano, P. C., Ahmed, Z., et al. (2008) Risperidone, haloperidol and placebo in the treatment of aggressive and challenging behavior in patients with intellectual disability: A randomized trial. Lancet, 371, 57–64.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported by the following cooperative agreement grants from the National Institute of Mental Health: U10MH66768 (P.I., M. Aman), U10MH66766 (P.I., C. McDougle), and U10MH66764 (P.I., L. Scahill). The views expressed in this article are those of the authors and do not necessarily reflect the official position of the National Institute of Mental Health, the National Institutes of Health, or any other part of the U.S. Department of Health and Human Services. The authors would like to acknowledge the following people: Ann Wagner, PhD, Louise Ritz, MBA, Stacie Trollinger, Patricia Shugarts, Allison Gavaletz, Kristy Hall, Arlene Kohn, Kathy Koenig, MSN, Maryellen Pachler, MSN, Sue Thompson, MSN, Roumen Niklov, MD, Kristina Siefker, MS, Kimberly Stigler, MD, Mariana Zaphiriou, Scientific Advisors, Data Safety and Monitoring Board.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Lawrence Scahill.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Scahill, L., Aman, M.G., McCracken, J.T. et al. Beware of Over-Interpreting Negative Trials. J Autism Dev Disord 38, 1609–1610 (2008). https://doi.org/10.1007/s10803-008-0581-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10803-008-0581-7

Navigation